Subscribe to Updates in Accounting & Financial Analysis

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Current or Former Chief Financial Officers in the Pharmaceuticals & Biotechnology Manufacturing and Research Industry(?)

Council Members in this Study Group: 88

This study group may include chief financial officers, chartered public accountants, controllers, and consultants knowledgeable on topics such as finance, taxation, auditing, forensic accounting and fraud, financial accounting and reporting, bankruptcy, pension benefits, cash flow, company valuation, working capital, hedge accounting, and mergers and acquisition, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Michael Stein, Board of Directors, Nautilus, Inc.Michael Stein
Board of Directors
Nautilus, Inc.

Michael Stein serves on the Boards of Directors at AIMCO, a real estate investment trust, and Nautilus, Inc., a fitness equipment company. He has over 35 years of diverse experience in finance, accounting and management. He was Chief Financial Officer at ICOS Corporation, a biotechnology company. Prior...

1 recent event(s)
Peter Culpepper, CPA, MBA, Chief Financial Officer, Provectus Pharmaceuticals, Inc.Peter Culpepper, CPA, MBA
Chief Financial Officer
Provectus Pharmaceuticals, Inc.

Peter Culpepper is the Chief Financial Officer at Provectus Pharmaceuticals. Mr. Culpepper has experience in prescription (therapeutic), biotech, healthcare OTC, specialty pharma, and medical device products. Previous to that, Mr. Culpepper served as the Chief Financial Officer at Felix Culpepper International,...

Related Study Groups

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Outsourcing is an American management cop-out | 07-26-2007
Analysis of: Going Away | www.cfoasia.com
Author: GLG Expert Contributor

I respectfully, but strongly, disagree with the Author's assertion that "Outsourcing is here to stay."  My comments are based upon a 30+ year management career, however, my evidence more solidly stems from the numerous disappointing interactions I have experienced as a CUSTOMER subjected to the...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Pharmaceuticals Manufacturer
  • Pharmaceuticals/Biotechnology Research Services
  • Biotechnology Manufacturer
  • Independent Consulting Firm
  • Consulting Firm

Most Common Job Types:

  • Chief Financial Officer
  • VP Finance
  • Director
  • Principal
  • President

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-05T09:45:16.717